News: As of January 1st, 2014 DiagnOptics Technologies B.V. moved to another location.
Diab-spot is a non-invasive test to identify people at risk for diabetes or pre-diabetes without overnight fasting, a blood draw, or waiting for a lab result.
The AGE Reader provides an immediate cardiovascular risk prediction in major chronic diseases such as diabetes, renal failure and cardiovascular disease.
Find a distributor in your country. If your country is not listed, please contact DiagnOptics for your enquiries: firstname.lastname@example.org
Groningen, the Netherlands - March 11, 2014. A recently published clinical paper by de Vos et al. (2014) demonstrates that the AGE Reader measurement is a str......» read more
The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or DiagnOptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.